Log in

NASDAQ:RNA - Prosensa Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume157,108 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:RNA
CUSIPN/A
Phone+31-71-3322100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive RNA News and Ratings via Email

Sign-up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter.


Prosensa (NASDAQ:RNA) Frequently Asked Questions

What is Prosensa's stock symbol?

Prosensa trades on the NASDAQ under the ticker symbol "RNA."

Has Prosensa been receiving favorable news coverage?

Press coverage about RNA stock has trended negative on Saturday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Prosensa earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the company's share price in the near future. View News Stories for Prosensa.

What other stocks do shareholders of Prosensa own?

How do I buy shares of Prosensa?

Shares of RNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Prosensa's official website?

The official website for Prosensa is http://www.prosensa.eu/.

How can I contact Prosensa?

Prosensa's mailing address is J.H. Oortweg 21, LEIDEN, 2333 CH, Netherlands. The biotechnology company can be reached via phone at +31-71-3322100.


MarketBeat Community Rating for Prosensa (NASDAQ RNA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  198
MarketBeat's community ratings are surveys of what our community members think about Prosensa and other stocks. Vote "Outperform" if you believe RNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel